Sesen Bio, Inc. - Common Stock (NQ:SESN)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Mar 7, 2023 Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	0.5811 (30)
Ask (Size)	0.6280 (9)
Prev. Close	0.6288
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	41,788,096
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 06, 2023

Via Benzinga

Why Hertz Global Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket ↗

March 06, 2023

Gainers Secoo Holding Limited (NASDAQ: SECO) rose 44% to $1.44 in pre-market trading after dipping over 31% on Friday.

Via Benzinga

Performance

More News

Sesen Bio Stockholders Approve Merger with Carisma Therapeutics

March 02, 2023

From Sesen Bio, Inc.

Via Business Wire

Sesen Bio Reports Fourth Quarter and Full-Year 2022 Financial Results

February 28, 2023

From Sesen Bio, Inc.

Via Business Wire

Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending That Sesen Bio Stockholders Vote “FOR” All Proposals to Approve Pending Merger With Carisma

February 21, 2023

From Sesen Bio, Inc.

Via Business Wire

Leading Independent Proxy Advisory Firm ISS Recommends Sesen Bio Stockholders Vote “FOR” All Proposals at March 2 Special Meeting

February 16, 2023

From Sesen Bio, Inc.

Via Business Wire

Sesen Bio to Host Webcast with Carisma Therapeutics to Discuss Pending Merger

February 16, 2023

From Sesen Bio, Inc.

Via Business Wire

BML, One of Sesen Bio’s Top Stockholders, Announces Support for Pending Merger with Carisma Therapeutics

February 15, 2023

From Sesen Bio, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 14, 2023

Via Benzinga

Sesen Bio and Carisma Therapeutics Announce Increased Special Cash Dividend and Stockholder Support for Pending Merger

February 14, 2023

From Sesen Bio, Inc.

Via Business Wire

Sesen Bio Files Investor Presentation in Connection with Pending Carisma Therapeutics Merger

February 02, 2023

From Sesen Bio, Inc.

Via Business Wire

Sesen Bio Receives NASDAQ Delisting Notice

January 30, 2023

From Sesen Bio, Inc.

Via Business Wire

Sesen Bio Reiterates Confidence that Pending Merger with Carisma is in Best Interests of Stockholders

January 26, 2023

From Sesen Bio, Inc.

Via Business Wire

Investor Group Issues Letter to the Boards of Sesen Bio and Carisma Rejecting Their Apparent Attempt to Purchase Merger Support

January 25, 2023

From On behalf of Bradley L. Radoff

Via Business Wire

Sesen Bio Files Definitive Proxy Statement and Mails Letter to Stockholders in Connection with Pending Merger with Carisma Therapeutics

January 19, 2023

From Sesen Bio, Inc.

Via Business Wire

Investor Group Issues Letter to Sesen Bio’s Board of Directors Regarding Intent to Vote AGAINST Proposed Carisma Merger

January 05, 2023

From On behalf of Bradley L. Radoff

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sesen Bio, Inc. (Nasdaq - SESN), IsoPlexis (Nasdaq - ISO), Trean Insurance Group, Inc. (Nasdaq - TIG), Brunswick Bancorp (OTC – BRBW)

January 04, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Sesen Bio Reiterates Confidence in Pending Merger with Carisma Therapeutics

January 04, 2023

From Sesen Bio, Inc.

Via Business Wire

Investor Group Reiterates Intent to Vote AGAINST Sesen Bio’s Value-Destructive Merger with Carisma

January 03, 2023

From On behalf of Bradley L. Radoff

Via Business Wire

Dow Falls 300 Points On Last Trading Session of 2022; S&P 500 Down 1% ↗

December 30, 2022

Via Benzinga

Why Sesen Bio Shares Are Skyrocketing Friday? ↗

December 30, 2022

Via Benzinga

Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session ↗

December 30, 2022

Via Benzinga

Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket ↗

December 30, 2022

Via Benzinga

Uxin, Heidrick & Struggles International And 3 Stocks To Watch Heading Into Friday ↗

December 30, 2022

Via Benzinga

Frequently Asked Questions

Is Sesen Bio, Inc. - Common Stock publicly traded?

Yes, Sesen Bio, Inc. - Common Stock is publicly traded.

What exchange does Sesen Bio, Inc. - Common Stock trade on?

Sesen Bio, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Sesen Bio, Inc. - Common Stock?

The ticker symbol for Sesen Bio, Inc. - Common Stock is SESN on the Nasdaq Stock Market